A ARISAPH CREATING SMART MEDICINES
Dead / Cancelled — Cancelled — Section 8 (as of 19 Nov 2021)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85190015
- Registration number
- 4703954
- Mark type
- Design + words
- Filed
- 03 Dec 2010
- Published for opposition
- 26 Apr 2011
- Registered
- 17 Mar 2015
- Attorney of record
- Joshua Jarvis
Goods and services
- Class 005 — Pharmaceuticals: Pharmacological preparations and substances for the treatment of diabetes and atherosclerosis
Owner
- Arisaph Pharmaceuticals, Inc., Boston, MA, US
- Arisaph Pharmaceuticals, Inc., Boston, MA, US
- Arisaph Pharmaceuticals, Inc., Boston, MA, US
Prior registrations
Prosecution history
- 19 Nov 2021 — CANCELLED SEC. 8 (6-YR)
- 17 Mar 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Mar 2015 — REGISTERED-PRINCIPAL REGISTER
- 12 Feb 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Feb 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Feb 2015 — EXAMINER'S AMENDMENT ENTERED
- 10 Feb 2015 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Feb 2015 — EXAMINERS AMENDMENT E-MAILED
- 10 Feb 2015 — SU-EXAMINER'S AMENDMENT WRITTEN
- 09 Feb 2015 — ASSIGNED TO EXAMINER
- 21 May 2014 — STATEMENT OF USE PROCESSING COMPLETE
- 16 May 2014 — USE AMENDMENT FILED
- 16 May 2014 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 16 May 2014 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 16 May 2014 — TEAS STATEMENT OF USE RECEIVED